nodes	percent_of_prediction	percent_of_DWPC	metapath
Dalfampridine—KCNB1—pulmonary artery—sarcoma	0.0674	0.118	CbGeAlD
Dalfampridine—KCNA5—pulmonary artery—sarcoma	0.0443	0.0778	CbGeAlD
Dalfampridine—KCNS3—pulmonary artery—sarcoma	0.0434	0.0762	CbGeAlD
Dalfampridine—KCNQ1—TarBasePathway—ERG—sarcoma	0.0416	0.235	CbGpPWpGaD
Dalfampridine—CYP2E1—Dacarbazine—sarcoma	0.0165	0.441	CbGbCtD
Dalfampridine—KCNH1—embryo—sarcoma	0.0134	0.0236	CbGeAlD
Dalfampridine—CYP2E1—Mitoxantrone—sarcoma	0.0128	0.343	CbGbCtD
Dalfampridine—KCNG1—myometrium—sarcoma	0.0125	0.0219	CbGeAlD
Dalfampridine—KCNG3—hematopoietic system—sarcoma	0.012	0.0211	CbGeAlD
Dalfampridine—KCNH1—hematopoietic system—sarcoma	0.012	0.0211	CbGeAlD
Dalfampridine—KCNA7—tendon—sarcoma	0.011	0.0193	CbGeAlD
Dalfampridine—KCNS2—uterus—sarcoma	0.0107	0.0187	CbGeAlD
Dalfampridine—KCNG2—testis—sarcoma	0.0102	0.0179	CbGeAlD
Dalfampridine—KCND1—embryo—sarcoma	0.00997	0.0175	CbGeAlD
Dalfampridine—KCNS1—seminal vesicle—sarcoma	0.00979	0.0172	CbGeAlD
Dalfampridine—KCNA3—hematopoietic system—sarcoma	0.00978	0.0172	CbGeAlD
Dalfampridine—KCNA2—hematopoietic system—sarcoma	0.0093	0.0163	CbGeAlD
Dalfampridine—KCNB1—smooth muscle tissue—sarcoma	0.00912	0.016	CbGeAlD
Dalfampridine—KCNF1—myometrium—sarcoma	0.00888	0.0156	CbGeAlD
Dalfampridine—KCNG3—lymphoid tissue—sarcoma	0.00845	0.0148	CbGeAlD
Dalfampridine—KCNG1—uterus—sarcoma	0.00808	0.0142	CbGeAlD
Dalfampridine—CYP2E1—Etoposide—sarcoma	0.00808	0.216	CbGbCtD
Dalfampridine—KCNF1—seminal vesicle—sarcoma	0.00802	0.0141	CbGeAlD
Dalfampridine—KCNS3—myometrium—sarcoma	0.00777	0.0137	CbGeAlD
Dalfampridine—KCNS3—seminal vesicle—sarcoma	0.00702	0.0123	CbGeAlD
Dalfampridine—KCNV2—testis—sarcoma	0.00689	0.0121	CbGeAlD
Dalfampridine—KCNA3—lymphoid tissue—sarcoma	0.00689	0.0121	CbGeAlD
Dalfampridine—KCND2—myometrium—sarcoma	0.00677	0.0119	CbGeAlD
Dalfampridine—KCNH2—Hematopoietic Stem Cell Differentiation—FLI1—sarcoma	0.00665	0.0375	CbGpPWpGaD
Dalfampridine—KCNH1—testis—sarcoma	0.00658	0.0115	CbGeAlD
Dalfampridine—KCNA5—connective tissue—sarcoma	0.00656	0.0115	CbGeAlD
Dalfampridine—KCNA5—smooth muscle tissue—sarcoma	0.006	0.0105	CbGeAlD
Dalfampridine—KCNC4—tendon—sarcoma	0.00589	0.0103	CbGeAlD
Dalfampridine—KCNH3—testis—sarcoma	0.00586	0.0103	CbGeAlD
Dalfampridine—KCNG1—testis—sarcoma	0.00586	0.0103	CbGeAlD
Dalfampridine—KCNS3—skin of body—sarcoma	0.0058	0.0102	CbGeAlD
Dalfampridine—KCNH8—testis—sarcoma	0.00568	0.00997	CbGeAlD
Dalfampridine—KCNQ4—tendon—sarcoma	0.00566	0.00994	CbGeAlD
Dalfampridine—KCNC3—testis—sarcoma	0.00551	0.00968	CbGeAlD
Dalfampridine—KCNQ5—tendon—sarcoma	0.0055	0.00967	CbGeAlD
Dalfampridine—KCNA5—cardiac atrium—sarcoma	0.00518	0.00909	CbGeAlD
Dalfampridine—KCNQ1—seminal vesicle—sarcoma	0.00517	0.00907	CbGeAlD
Dalfampridine—KCNS1—testis—sarcoma	0.0051	0.00895	CbGeAlD
Dalfampridine—KCNA2—testis—sarcoma	0.0051	0.00895	CbGeAlD
Dalfampridine—KCNF1—tendon—sarcoma	0.00504	0.00886	CbGeAlD
Dalfampridine—KCNC4—testis—sarcoma	0.00488	0.00856	CbGeAlD
Dalfampridine—KCND1—testis—sarcoma	0.00488	0.00856	CbGeAlD
Dalfampridine—KCNC1—testis—sarcoma	0.00469	0.00823	CbGeAlD
Dalfampridine—KCNH7—testis—sarcoma	0.00469	0.00823	CbGeAlD
Dalfampridine—KCNQ4—testis—sarcoma	0.00469	0.00823	CbGeAlD
Dalfampridine—KCNH6—uterus—sarcoma	0.0046	0.00808	CbGeAlD
Dalfampridine—KCNA5—tendon—sarcoma	0.00451	0.00792	CbGeAlD
Dalfampridine—KCNS3—tendon—sarcoma	0.00442	0.00776	CbGeAlD
Dalfampridine—Chest discomfort—Etoposide—sarcoma	0.00415	0.0192	CcSEcCtD
Dalfampridine—KCNA3—lymph node—sarcoma	0.00389	0.00682	CbGeAlD
Dalfampridine—KCND3—cardiac atrium—sarcoma	0.00385	0.00676	CbGeAlD
Dalfampridine—KCND3—uterus—sarcoma	0.00383	0.00673	CbGeAlD
Dalfampridine—KCNB1—Calcium Regulation in the Cardiac Cell—GJA4—sarcoma	0.00376	0.0212	CbGpPWpGaD
Dalfampridine—KCNA5—testis—sarcoma	0.00374	0.00656	CbGeAlD
Dalfampridine—KCNQ1—cardiac atrium—sarcoma	0.00373	0.00655	CbGeAlD
Dalfampridine—KCNA2—lymph node—sarcoma	0.0037	0.00649	CbGeAlD
Dalfampridine—KCNS3—testis—sarcoma	0.00366	0.00642	CbGeAlD
Dalfampridine—KCNC4—lymph node—sarcoma	0.00353	0.00621	CbGeAlD
Dalfampridine—KCNS3—liver—sarcoma	0.00346	0.00607	CbGeAlD
Dalfampridine—KCNA1—tendon—sarcoma	0.00337	0.00592	CbGeAlD
Dalfampridine—KCNQ2—testis—sarcoma	0.00337	0.00591	CbGeAlD
Dalfampridine—KCNQ5—lymph node—sarcoma	0.0033	0.0058	CbGeAlD
Dalfampridine—KCNQ3—L1CAM interactions—EZR—sarcoma	0.00324	0.0183	CbGpPWpGaD
Dalfampridine—KCNQ2—L1CAM interactions—EZR—sarcoma	0.00324	0.0183	CbGpPWpGaD
Dalfampridine—KCND2—testis—sarcoma	0.00319	0.0056	CbGeAlD
Dalfampridine—KCNQ1—bone marrow—sarcoma	0.00315	0.00553	CbGeAlD
Dalfampridine—KCNH2—Hematopoietic Stem Cell Differentiation—CSF3—sarcoma	0.00315	0.0177	CbGpPWpGaD
Dalfampridine—Infestation—Thiotepa—sarcoma	0.00286	0.0133	CcSEcCtD
Dalfampridine—Infestation NOS—Thiotepa—sarcoma	0.00286	0.0133	CcSEcCtD
Dalfampridine—KCND3—testis—sarcoma	0.00278	0.00488	CbGeAlD
Dalfampridine—KCNA5—lymph node—sarcoma	0.00271	0.00476	CbGeAlD
Dalfampridine—KCNQ1—testis—sarcoma	0.00269	0.00473	CbGeAlD
Dalfampridine—KCNS3—lymph node—sarcoma	0.00265	0.00466	CbGeAlD
Dalfampridine—KCND3—liver—sarcoma	0.00263	0.00461	CbGeAlD
Dalfampridine—KCNA3—BDNF signaling pathway—PLCG1—sarcoma	0.00262	0.0148	CbGpPWpGaD
Dalfampridine—KCNQ1—liver—sarcoma	0.00254	0.00447	CbGeAlD
Dalfampridine—Connective tissue disorder—Thiotepa—sarcoma	0.00252	0.0117	CcSEcCtD
Dalfampridine—Urinary tract infection—Mitoxantrone—sarcoma	0.0024	0.0111	CcSEcCtD
Dalfampridine—Angiopathy—Thiotepa—sarcoma	0.00233	0.0108	CcSEcCtD
Dalfampridine—Immune system disorder—Thiotepa—sarcoma	0.00232	0.0108	CcSEcCtD
Dalfampridine—Mediastinal disorder—Thiotepa—sarcoma	0.00232	0.0107	CcSEcCtD
Dalfampridine—Mental disorder—Thiotepa—sarcoma	0.00225	0.0104	CcSEcCtD
Dalfampridine—Connective tissue disorder—Vincristine—sarcoma	0.00224	0.0104	CcSEcCtD
Dalfampridine—KCNH2—myometrium—sarcoma	0.00218	0.00383	CbGeAlD
Dalfampridine—Back pain—Thiotepa—sarcoma	0.00216	0.01	CcSEcCtD
Dalfampridine—Angiopathy—Vincristine—sarcoma	0.00207	0.00958	CcSEcCtD
Dalfampridine—Infestation NOS—Etoposide—sarcoma	0.00206	0.00952	CcSEcCtD
Dalfampridine—Infestation—Etoposide—sarcoma	0.00206	0.00952	CcSEcCtD
Dalfampridine—Mediastinal disorder—Vincristine—sarcoma	0.00205	0.00951	CcSEcCtD
Dalfampridine—KCND3—lymph node—sarcoma	0.00201	0.00354	CbGeAlD
Dalfampridine—Mental disorder—Vincristine—sarcoma	0.002	0.00925	CcSEcCtD
Dalfampridine—KCNH2—seminal vesicle—sarcoma	0.00197	0.00346	CbGeAlD
Dalfampridine—KCNQ1—lymph node—sarcoma	0.00195	0.00343	CbGeAlD
Dalfampridine—Convulsion—Thiotepa—sarcoma	0.00194	0.00898	CcSEcCtD
Dalfampridine—Back pain—Vincristine—sarcoma	0.00192	0.00889	CcSEcCtD
Dalfampridine—Anxiety—Thiotepa—sarcoma	0.0019	0.00879	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.00189	0.00876	CcSEcCtD
Dalfampridine—KCNH2—hematopoietic system—sarcoma	0.00187	0.00329	CbGeAlD
Dalfampridine—Back pain—Mitoxantrone—sarcoma	0.00187	0.00865	CcSEcCtD
Dalfampridine—Confusional state—Thiotepa—sarcoma	0.00184	0.00853	CcSEcCtD
Dalfampridine—Infection—Thiotepa—sarcoma	0.00181	0.0084	CcSEcCtD
Dalfampridine—Infection—Dactinomycin—sarcoma	0.0018	0.00834	CcSEcCtD
Dalfampridine—KCNH2—Hematopoietic Stem Cell Differentiation—CXCR4—sarcoma	0.0018	0.0102	CbGpPWpGaD
Dalfampridine—Nervous system disorder—Thiotepa—sarcoma	0.00179	0.00829	CcSEcCtD
Dalfampridine—Skin disorder—Thiotepa—sarcoma	0.00177	0.00821	CcSEcCtD
Dalfampridine—Convulsion—Vincristine—sarcoma	0.00172	0.00796	CcSEcCtD
Dalfampridine—Angiopathy—Etoposide—sarcoma	0.00167	0.00776	CcSEcCtD
Dalfampridine—Convulsion—Mitoxantrone—sarcoma	0.00167	0.00775	CcSEcCtD
Dalfampridine—Immune system disorder—Etoposide—sarcoma	0.00167	0.00772	CcSEcCtD
Dalfampridine—Mediastinal disorder—Etoposide—sarcoma	0.00166	0.00771	CcSEcCtD
Dalfampridine—Chest pain—Mitoxantrone—sarcoma	0.00164	0.00762	CcSEcCtD
Dalfampridine—Paraesthesia—Thiotepa—sarcoma	0.00164	0.00759	CcSEcCtD
Dalfampridine—Anxiety—Mitoxantrone—sarcoma	0.00164	0.00759	CcSEcCtD
Dalfampridine—Anaphylactic shock—Vincristine—sarcoma	0.00162	0.0075	CcSEcCtD
Dalfampridine—Infection—Vincristine—sarcoma	0.00161	0.00745	CcSEcCtD
Dalfampridine—Dyspepsia—Thiotepa—sarcoma	0.00161	0.00744	CcSEcCtD
Dalfampridine—Confusional state—Mitoxantrone—sarcoma	0.00159	0.00736	CcSEcCtD
Dalfampridine—Nervous system disorder—Vincristine—sarcoma	0.00159	0.00735	CcSEcCtD
Dalfampridine—Anaphylactic shock—Mitoxantrone—sarcoma	0.00158	0.0073	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Thiotepa—sarcoma	0.00158	0.0073	CcSEcCtD
Dalfampridine—Infection—Mitoxantrone—sarcoma	0.00157	0.00725	CcSEcCtD
Dalfampridine—Constipation—Thiotepa—sarcoma	0.00156	0.00723	CcSEcCtD
Dalfampridine—Back pain—Etoposide—sarcoma	0.00155	0.0072	CcSEcCtD
Dalfampridine—Skin disorder—Mitoxantrone—sarcoma	0.00153	0.00709	CcSEcCtD
Dalfampridine—CYP2E1—seminal vesicle—sarcoma	0.00152	0.00266	CbGeAlD
Dalfampridine—Hypotension—Vincristine—sarcoma	0.00151	0.00701	CcSEcCtD
Dalfampridine—Feeling abnormal—Thiotepa—sarcoma	0.0015	0.00697	CcSEcCtD
Dalfampridine—Feeling abnormal—Dactinomycin—sarcoma	0.00149	0.00692	CcSEcCtD
Dalfampridine—Hypotension—Mitoxantrone—sarcoma	0.00147	0.00682	CcSEcCtD
Dalfampridine—Insomnia—Vincristine—sarcoma	0.00146	0.00678	CcSEcCtD
Dalfampridine—Paraesthesia—Vincristine—sarcoma	0.00145	0.00673	CcSEcCtD
Dalfampridine—Urticaria—Thiotepa—sarcoma	0.00145	0.00672	CcSEcCtD
Dalfampridine—CYP2E1—hematopoietic system—sarcoma	0.00144	0.00253	CbGeAlD
Dalfampridine—CYP2E1—Folate-Alcohol and Cancer Pathway—CREB1—sarcoma	0.00144	0.00812	CbGpPWpGaD
Dalfampridine—KCNH2—cardiac atrium—sarcoma	0.00142	0.0025	CbGeAlD
Dalfampridine—Paraesthesia—Mitoxantrone—sarcoma	0.00142	0.00656	CcSEcCtD
Dalfampridine—KCNH2—uterus—sarcoma	0.00141	0.00248	CbGeAlD
Dalfampridine—Dyspnoea—Mitoxantrone—sarcoma	0.00141	0.00651	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Vincristine—sarcoma	0.0014	0.00647	CcSEcCtD
Dalfampridine—Convulsion—Etoposide—sarcoma	0.00139	0.00645	CcSEcCtD
Dalfampridine—Dyspepsia—Mitoxantrone—sarcoma	0.00139	0.00643	CcSEcCtD
Dalfampridine—Constipation—Vincristine—sarcoma	0.00138	0.00641	CcSEcCtD
Dalfampridine—Chest pain—Etoposide—sarcoma	0.00137	0.00634	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00136	0.00629	CcSEcCtD
Dalfampridine—KCNA3—BDNF signaling pathway—CREB1—sarcoma	0.00135	0.00761	CbGpPWpGaD
Dalfampridine—Constipation—Mitoxantrone—sarcoma	0.00135	0.00624	CcSEcCtD
Dalfampridine—Hypersensitivity—Thiotepa—sarcoma	0.00134	0.00623	CcSEcCtD
Dalfampridine—Nasopharyngitis—Epirubicin—sarcoma	0.00134	0.00619	CcSEcCtD
Dalfampridine—Hypersensitivity—Dactinomycin—sarcoma	0.00133	0.00618	CcSEcCtD
Dalfampridine—Confusional state—Etoposide—sarcoma	0.00132	0.00612	CcSEcCtD
Dalfampridine—Anaphylactic shock—Etoposide—sarcoma	0.00131	0.00607	CcSEcCtD
Dalfampridine—Asthenia—Thiotepa—sarcoma	0.00131	0.00607	CcSEcCtD
Dalfampridine—Infection—Etoposide—sarcoma	0.0013	0.00603	CcSEcCtD
Dalfampridine—Asthenia—Dactinomycin—sarcoma	0.0013	0.00602	CcSEcCtD
Dalfampridine—Feeling abnormal—Mitoxantrone—sarcoma	0.0013	0.00602	CcSEcCtD
Dalfampridine—Skin disorder—Etoposide—sarcoma	0.00127	0.0059	CcSEcCtD
Dalfampridine—Urticaria—Mitoxantrone—sarcoma	0.00125	0.0058	CcSEcCtD
Dalfampridine—Nasopharyngitis—Doxorubicin—sarcoma	0.00124	0.00573	CcSEcCtD
Dalfampridine—Hypotension—Etoposide—sarcoma	0.00123	0.00568	CcSEcCtD
Dalfampridine—KCNQ3—Axon guidance—EZR—sarcoma	0.00122	0.0069	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—EZR—sarcoma	0.00122	0.0069	CbGpPWpGaD
Dalfampridine—Dizziness—Thiotepa—sarcoma	0.00121	0.00559	CcSEcCtD
Dalfampridine—KCNH2—bone marrow—sarcoma	0.0012	0.00211	CbGeAlD
Dalfampridine—Hypersensitivity—Vincristine—sarcoma	0.00119	0.00552	CcSEcCtD
Dalfampridine—Paraesthesia—Etoposide—sarcoma	0.00118	0.00545	CcSEcCtD
Dalfampridine—Dyspnoea—Etoposide—sarcoma	0.00117	0.00542	CcSEcCtD
Dalfampridine—Hypersensitivity—Mitoxantrone—sarcoma	0.00116	0.00538	CcSEcCtD
Dalfampridine—Asthenia—Vincristine—sarcoma	0.00116	0.00538	CcSEcCtD
Dalfampridine—Vomiting—Thiotepa—sarcoma	0.00116	0.00538	CcSEcCtD
Dalfampridine—Infestation—Epirubicin—sarcoma	0.00115	0.00534	CcSEcCtD
Dalfampridine—Infestation NOS—Epirubicin—sarcoma	0.00115	0.00534	CcSEcCtD
Dalfampridine—KCNQ3—Developmental Biology—MYOG—sarcoma	0.00115	0.0065	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MYOG—sarcoma	0.00115	0.0065	CbGpPWpGaD
Dalfampridine—Vomiting—Dactinomycin—sarcoma	0.00115	0.00534	CcSEcCtD
Dalfampridine—Rash—Thiotepa—sarcoma	0.00115	0.00533	CcSEcCtD
Dalfampridine—Dermatitis—Thiotepa—sarcoma	0.00115	0.00533	CcSEcCtD
Dalfampridine—Headache—Thiotepa—sarcoma	0.00114	0.0053	CcSEcCtD
Dalfampridine—Rash—Dactinomycin—sarcoma	0.00114	0.00529	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Etoposide—sarcoma	0.00113	0.00524	CcSEcCtD
Dalfampridine—Asthenia—Mitoxantrone—sarcoma	0.00113	0.00524	CcSEcCtD
Dalfampridine—Constipation—Etoposide—sarcoma	0.00112	0.00519	CcSEcCtD
Dalfampridine—Urinary tract infection—Epirubicin—sarcoma	0.00112	0.00519	CcSEcCtD
Dalfampridine—Nausea—Thiotepa—sarcoma	0.00108	0.00502	CcSEcCtD
Dalfampridine—Feeling abnormal—Etoposide—sarcoma	0.00108	0.00501	CcSEcCtD
Dalfampridine—Nausea—Dactinomycin—sarcoma	0.00108	0.00499	CcSEcCtD
Dalfampridine—Dizziness—Vincristine—sarcoma	0.00107	0.00496	CcSEcCtD
Dalfampridine—Infestation NOS—Doxorubicin—sarcoma	0.00107	0.00494	CcSEcCtD
Dalfampridine—Infestation—Doxorubicin—sarcoma	0.00107	0.00494	CcSEcCtD
Dalfampridine—Urticaria—Etoposide—sarcoma	0.00104	0.00483	CcSEcCtD
Dalfampridine—Urinary tract infection—Doxorubicin—sarcoma	0.00104	0.0048	CcSEcCtD
Dalfampridine—Vomiting—Vincristine—sarcoma	0.00103	0.00477	CcSEcCtD
Dalfampridine—KCNH2—testis—sarcoma	0.00103	0.0018	CbGeAlD
Dalfampridine—Rash—Vincristine—sarcoma	0.00102	0.00473	CcSEcCtD
Dalfampridine—Dermatitis—Vincristine—sarcoma	0.00102	0.00472	CcSEcCtD
Dalfampridine—Connective tissue disorder—Epirubicin—sarcoma	0.00102	0.00471	CcSEcCtD
Dalfampridine—CYP2E1—lymphoid tissue—sarcoma	0.00102	0.00178	CbGeAlD
Dalfampridine—Headache—Vincristine—sarcoma	0.00101	0.0047	CcSEcCtD
Dalfampridine—Vomiting—Mitoxantrone—sarcoma	0.001	0.00464	CcSEcCtD
Dalfampridine—Rash—Mitoxantrone—sarcoma	0.000994	0.0046	CcSEcCtD
Dalfampridine—Dermatitis—Mitoxantrone—sarcoma	0.000993	0.0046	CcSEcCtD
Dalfampridine—Headache—Mitoxantrone—sarcoma	0.000988	0.00457	CcSEcCtD
Dalfampridine—KCNA3—BDNF signaling pathway—JUN—sarcoma	0.00097	0.00547	CbGpPWpGaD
Dalfampridine—Hypersensitivity—Etoposide—sarcoma	0.000966	0.00448	CcSEcCtD
Dalfampridine—KCNA3—BDNF signaling pathway—CTNNB1—sarcoma	0.000962	0.00543	CbGpPWpGaD
Dalfampridine—Nausea—Vincristine—sarcoma	0.000962	0.00445	CcSEcCtD
Dalfampridine—CYP2E1—tendon—sarcoma	0.000954	0.00168	CbGeAlD
Dalfampridine—Asthenia—Etoposide—sarcoma	0.000941	0.00436	CcSEcCtD
Dalfampridine—Connective tissue disorder—Doxorubicin—sarcoma	0.000941	0.00436	CcSEcCtD
Dalfampridine—Angiopathy—Epirubicin—sarcoma	0.000939	0.00435	CcSEcCtD
Dalfampridine—Nausea—Mitoxantrone—sarcoma	0.000936	0.00434	CcSEcCtD
Dalfampridine—Immune system disorder—Epirubicin—sarcoma	0.000934	0.00433	CcSEcCtD
Dalfampridine—Mediastinal disorder—Epirubicin—sarcoma	0.000932	0.00432	CcSEcCtD
Dalfampridine—Mental disorder—Epirubicin—sarcoma	0.000906	0.0042	CcSEcCtD
Dalfampridine—KCNF1—Neuronal System—CREB1—sarcoma	0.000891	0.00503	CbGpPWpGaD
Dalfampridine—KCND1—Neuronal System—CREB1—sarcoma	0.000891	0.00503	CbGpPWpGaD
Dalfampridine—KCNH1—Neuronal System—CREB1—sarcoma	0.000891	0.00503	CbGpPWpGaD
Dalfampridine—KCNS2—Neuronal System—CREB1—sarcoma	0.000891	0.00503	CbGpPWpGaD
Dalfampridine—KCNA6—Neuronal System—CREB1—sarcoma	0.000891	0.00503	CbGpPWpGaD
Dalfampridine—KCNA10—Neuronal System—CREB1—sarcoma	0.000891	0.00503	CbGpPWpGaD
Dalfampridine—KCNA4—Neuronal System—CREB1—sarcoma	0.000891	0.00503	CbGpPWpGaD
Dalfampridine—KCNA7—Neuronal System—CREB1—sarcoma	0.000891	0.00503	CbGpPWpGaD
Dalfampridine—KCNC1—Neuronal System—CREB1—sarcoma	0.000891	0.00503	CbGpPWpGaD
Dalfampridine—KCNG3—Neuronal System—CREB1—sarcoma	0.000891	0.00503	CbGpPWpGaD
Dalfampridine—KCNG1—Neuronal System—CREB1—sarcoma	0.000891	0.00503	CbGpPWpGaD
Dalfampridine—KCNC3—Neuronal System—CREB1—sarcoma	0.000891	0.00503	CbGpPWpGaD
Dalfampridine—KCNG4—Neuronal System—CREB1—sarcoma	0.000891	0.00503	CbGpPWpGaD
Dalfampridine—KCNS1—Neuronal System—CREB1—sarcoma	0.000891	0.00503	CbGpPWpGaD
Dalfampridine—KCNA5—Neuronal System—CREB1—sarcoma	0.000891	0.00503	CbGpPWpGaD
Dalfampridine—KCNH8—Neuronal System—CREB1—sarcoma	0.000891	0.00503	CbGpPWpGaD
Dalfampridine—KCNC4—Neuronal System—CREB1—sarcoma	0.000891	0.00503	CbGpPWpGaD
Dalfampridine—KCNH4—Neuronal System—CREB1—sarcoma	0.000891	0.00503	CbGpPWpGaD
Dalfampridine—KCNH5—Neuronal System—CREB1—sarcoma	0.000891	0.00503	CbGpPWpGaD
Dalfampridine—KCNV1—Neuronal System—CREB1—sarcoma	0.000891	0.00503	CbGpPWpGaD
Dalfampridine—KCNB2—Neuronal System—CREB1—sarcoma	0.000891	0.00503	CbGpPWpGaD
Dalfampridine—KCNH3—Neuronal System—CREB1—sarcoma	0.000891	0.00503	CbGpPWpGaD
Dalfampridine—KCNA2—Neuronal System—CREB1—sarcoma	0.000891	0.00503	CbGpPWpGaD
Dalfampridine—KCNV2—Neuronal System—CREB1—sarcoma	0.000891	0.00503	CbGpPWpGaD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—CREB1—sarcoma	0.000877	0.00495	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—EZR—sarcoma	0.000873	0.00492	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—EZR—sarcoma	0.000873	0.00492	CbGpPWpGaD
Dalfampridine—Back pain—Epirubicin—sarcoma	0.000871	0.00404	CcSEcCtD
Dalfampridine—KCNA3—BDNF signaling pathway—SRC—sarcoma	0.00087	0.00491	CbGpPWpGaD
Dalfampridine—Angiopathy—Doxorubicin—sarcoma	0.000869	0.00402	CcSEcCtD
Dalfampridine—Dizziness—Etoposide—sarcoma	0.000867	0.00402	CcSEcCtD
Dalfampridine—Immune system disorder—Doxorubicin—sarcoma	0.000865	0.00401	CcSEcCtD
Dalfampridine—Mediastinal disorder—Doxorubicin—sarcoma	0.000863	0.004	CcSEcCtD
Dalfampridine—Mental disorder—Doxorubicin—sarcoma	0.000839	0.00388	CcSEcCtD
Dalfampridine—Vomiting—Etoposide—sarcoma	0.000834	0.00386	CcSEcCtD
Dalfampridine—Rash—Etoposide—sarcoma	0.000827	0.00383	CcSEcCtD
Dalfampridine—Dermatitis—Etoposide—sarcoma	0.000826	0.00383	CcSEcCtD
Dalfampridine—Headache—Etoposide—sarcoma	0.000821	0.00381	CcSEcCtD
Dalfampridine—Back pain—Doxorubicin—sarcoma	0.000806	0.00373	CcSEcCtD
Dalfampridine—KCNA3—Neuronal System—CREB1—sarcoma	0.000794	0.00448	CbGpPWpGaD
Dalfampridine—CYP2E1—testis—sarcoma	0.00079	0.00139	CbGeAlD
Dalfampridine—Convulsion—Epirubicin—sarcoma	0.00078	0.00361	CcSEcCtD
Dalfampridine—Nausea—Etoposide—sarcoma	0.000779	0.00361	CcSEcCtD
Dalfampridine—Chest pain—Epirubicin—sarcoma	0.000767	0.00355	CcSEcCtD
Dalfampridine—Anxiety—Epirubicin—sarcoma	0.000764	0.00354	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000761	0.00353	CcSEcCtD
Dalfampridine—KCNQ4—Neuronal System—CREB1—sarcoma	0.000758	0.00427	CbGpPWpGaD
Dalfampridine—KCNQ5—Neuronal System—CREB1—sarcoma	0.000758	0.00427	CbGpPWpGaD
Dalfampridine—CYP2E1—liver—sarcoma	0.000747	0.00131	CbGeAlD
Dalfampridine—KCNH2—lymph node—sarcoma	0.000744	0.00131	CbGeAlD
Dalfampridine—Confusional state—Epirubicin—sarcoma	0.000741	0.00343	CcSEcCtD
Dalfampridine—KCNG1—Neuronal System—MDM2—sarcoma	0.000738	0.00416	CbGpPWpGaD
Dalfampridine—KCNG4—Neuronal System—MDM2—sarcoma	0.000738	0.00416	CbGpPWpGaD
Dalfampridine—KCNC4—Neuronal System—MDM2—sarcoma	0.000738	0.00416	CbGpPWpGaD
Dalfampridine—KCNH8—Neuronal System—MDM2—sarcoma	0.000738	0.00416	CbGpPWpGaD
Dalfampridine—KCNV1—Neuronal System—MDM2—sarcoma	0.000738	0.00416	CbGpPWpGaD
Dalfampridine—KCNA5—Neuronal System—MDM2—sarcoma	0.000738	0.00416	CbGpPWpGaD
Dalfampridine—KCNA2—Neuronal System—MDM2—sarcoma	0.000738	0.00416	CbGpPWpGaD
Dalfampridine—KCNH4—Neuronal System—MDM2—sarcoma	0.000738	0.00416	CbGpPWpGaD
Dalfampridine—KCNH5—Neuronal System—MDM2—sarcoma	0.000738	0.00416	CbGpPWpGaD
Dalfampridine—KCNF1—Neuronal System—MDM2—sarcoma	0.000738	0.00416	CbGpPWpGaD
Dalfampridine—KCNC3—Neuronal System—MDM2—sarcoma	0.000738	0.00416	CbGpPWpGaD
Dalfampridine—KCNH3—Neuronal System—MDM2—sarcoma	0.000738	0.00416	CbGpPWpGaD
Dalfampridine—KCNB2—Neuronal System—MDM2—sarcoma	0.000738	0.00416	CbGpPWpGaD
Dalfampridine—KCNV2—Neuronal System—MDM2—sarcoma	0.000738	0.00416	CbGpPWpGaD
Dalfampridine—KCNA10—Neuronal System—MDM2—sarcoma	0.000738	0.00416	CbGpPWpGaD
Dalfampridine—KCNG3—Neuronal System—MDM2—sarcoma	0.000738	0.00416	CbGpPWpGaD
Dalfampridine—KCNA7—Neuronal System—MDM2—sarcoma	0.000738	0.00416	CbGpPWpGaD
Dalfampridine—KCNS1—Neuronal System—MDM2—sarcoma	0.000738	0.00416	CbGpPWpGaD
Dalfampridine—KCNA4—Neuronal System—MDM2—sarcoma	0.000738	0.00416	CbGpPWpGaD
Dalfampridine—KCND1—Neuronal System—MDM2—sarcoma	0.000738	0.00416	CbGpPWpGaD
Dalfampridine—KCNC1—Neuronal System—MDM2—sarcoma	0.000738	0.00416	CbGpPWpGaD
Dalfampridine—KCNH1—Neuronal System—MDM2—sarcoma	0.000738	0.00416	CbGpPWpGaD
Dalfampridine—KCNA6—Neuronal System—MDM2—sarcoma	0.000738	0.00416	CbGpPWpGaD
Dalfampridine—KCNS2—Neuronal System—MDM2—sarcoma	0.000738	0.00416	CbGpPWpGaD
Dalfampridine—Anaphylactic shock—Epirubicin—sarcoma	0.000735	0.0034	CcSEcCtD
Dalfampridine—Infection—Epirubicin—sarcoma	0.00073	0.00338	CcSEcCtD
Dalfampridine—Convulsion—Doxorubicin—sarcoma	0.000722	0.00334	CcSEcCtD
Dalfampridine—KCNQ3—Axon guidance—PTPRC—sarcoma	0.000721	0.00407	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—PTPRC—sarcoma	0.000721	0.00407	CbGpPWpGaD
Dalfampridine—Nervous system disorder—Epirubicin—sarcoma	0.000721	0.00334	CcSEcCtD
Dalfampridine—KCND2—Circadian rythm related genes—CREB1—sarcoma	0.000716	0.00404	CbGpPWpGaD
Dalfampridine—Skin disorder—Epirubicin—sarcoma	0.000714	0.00331	CcSEcCtD
Dalfampridine—KCNQ2—Developmental Biology—MYOD1—sarcoma	0.000712	0.00401	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MYOD1—sarcoma	0.000712	0.00401	CbGpPWpGaD
Dalfampridine—Chest pain—Doxorubicin—sarcoma	0.000709	0.00329	CcSEcCtD
Dalfampridine—Anxiety—Doxorubicin—sarcoma	0.000707	0.00327	CcSEcCtD
Dalfampridine—KCNQ2—Axon guidance—PLCG1—sarcoma	0.000706	0.00398	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—PLCG1—sarcoma	0.000706	0.00398	CbGpPWpGaD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000705	0.00326	CcSEcCtD
Dalfampridine—Hypotension—Epirubicin—sarcoma	0.000687	0.00318	CcSEcCtD
Dalfampridine—Confusional state—Doxorubicin—sarcoma	0.000686	0.00318	CcSEcCtD
Dalfampridine—Anaphylactic shock—Doxorubicin—sarcoma	0.00068	0.00315	CcSEcCtD
Dalfampridine—Infection—Doxorubicin—sarcoma	0.000676	0.00313	CcSEcCtD
Dalfampridine—Nervous system disorder—Doxorubicin—sarcoma	0.000667	0.00309	CcSEcCtD
Dalfampridine—Insomnia—Epirubicin—sarcoma	0.000665	0.00308	CcSEcCtD
Dalfampridine—Skin disorder—Doxorubicin—sarcoma	0.000661	0.00306	CcSEcCtD
Dalfampridine—Paraesthesia—Epirubicin—sarcoma	0.00066	0.00306	CcSEcCtD
Dalfampridine—KCNA3—Neuronal System—MDM2—sarcoma	0.000657	0.00371	CbGpPWpGaD
Dalfampridine—Dyspnoea—Epirubicin—sarcoma	0.000655	0.00304	CcSEcCtD
Dalfampridine—Dyspepsia—Epirubicin—sarcoma	0.000647	0.003	CcSEcCtD
Dalfampridine—Hypotension—Doxorubicin—sarcoma	0.000636	0.00294	CcSEcCtD
Dalfampridine—KCNG2—Neuronal System—CREB1—sarcoma	0.000635	0.00358	CbGpPWpGaD
Dalfampridine—KCNS3—Neuronal System—CREB1—sarcoma	0.000635	0.00358	CbGpPWpGaD
Dalfampridine—KCNC2—Neuronal System—CREB1—sarcoma	0.000635	0.00358	CbGpPWpGaD
Dalfampridine—Gastrointestinal disorder—Epirubicin—sarcoma	0.000635	0.00294	CcSEcCtD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—JUN—sarcoma	0.000631	0.00356	CbGpPWpGaD
Dalfampridine—Constipation—Epirubicin—sarcoma	0.000629	0.00291	CcSEcCtD
Dalfampridine—KCNQ4—Neuronal System—MDM2—sarcoma	0.000627	0.00354	CbGpPWpGaD
Dalfampridine—KCNQ5—Neuronal System—MDM2—sarcoma	0.000627	0.00354	CbGpPWpGaD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—CTNNB1—sarcoma	0.000626	0.00353	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—CREB1—sarcoma	0.000626	0.00353	CbGpPWpGaD
Dalfampridine—KCNQ2—L1CAM interactions—SRC—sarcoma	0.00062	0.0035	CbGpPWpGaD
Dalfampridine—KCNQ3—L1CAM interactions—SRC—sarcoma	0.00062	0.0035	CbGpPWpGaD
Dalfampridine—KCND3—Neuronal System—CREB1—sarcoma	0.000618	0.00348	CbGpPWpGaD
Dalfampridine—Insomnia—Doxorubicin—sarcoma	0.000615	0.00285	CcSEcCtD
Dalfampridine—KCNA3—BDNF signaling pathway—HRAS—sarcoma	0.000612	0.00345	CbGpPWpGaD
Dalfampridine—Paraesthesia—Doxorubicin—sarcoma	0.000611	0.00283	CcSEcCtD
Dalfampridine—Dyspnoea—Doxorubicin—sarcoma	0.000606	0.00281	CcSEcCtD
Dalfampridine—Feeling abnormal—Epirubicin—sarcoma	0.000606	0.00281	CcSEcCtD
Dalfampridine—KCNB1—Neuronal System—CREB1—sarcoma	0.000602	0.0034	CbGpPWpGaD
Dalfampridine—Dyspepsia—Doxorubicin—sarcoma	0.000599	0.00277	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000587	0.00272	CcSEcCtD
Dalfampridine—Urticaria—Epirubicin—sarcoma	0.000584	0.0027	CcSEcCtD
Dalfampridine—Constipation—Doxorubicin—sarcoma	0.000582	0.00269	CcSEcCtD
Dalfampridine—Feeling abnormal—Doxorubicin—sarcoma	0.00056	0.0026	CcSEcCtD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—VEGFA—sarcoma	0.000551	0.00311	CbGpPWpGaD
Dalfampridine—KCNQ1—Neuronal System—CREB1—sarcoma	0.000551	0.00311	CbGpPWpGaD
Dalfampridine—KCND2—Neuronal System—CREB1—sarcoma	0.000551	0.00311	CbGpPWpGaD
Dalfampridine—KCNQ2—L1CAM interactions—EGFR—sarcoma	0.000543	0.00306	CbGpPWpGaD
Dalfampridine—KCNQ3—L1CAM interactions—EGFR—sarcoma	0.000543	0.00306	CbGpPWpGaD
Dalfampridine—Hypersensitivity—Epirubicin—sarcoma	0.000542	0.00251	CcSEcCtD
Dalfampridine—Urticaria—Doxorubicin—sarcoma	0.00054	0.0025	CcSEcCtD
Dalfampridine—KCNH6—Neuronal System—CREB1—sarcoma	0.00054	0.00305	CbGpPWpGaD
Dalfampridine—Asthenia—Epirubicin—sarcoma	0.000527	0.00244	CcSEcCtD
Dalfampridine—KCNC2—Neuronal System—MDM2—sarcoma	0.000526	0.00296	CbGpPWpGaD
Dalfampridine—KCNG2—Neuronal System—MDM2—sarcoma	0.000526	0.00296	CbGpPWpGaD
Dalfampridine—KCNS3—Neuronal System—MDM2—sarcoma	0.000526	0.00296	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—JUN—sarcoma	0.000515	0.0029	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—PTPRC—sarcoma	0.000515	0.0029	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—PTPRC—sarcoma	0.000515	0.0029	CbGpPWpGaD
Dalfampridine—KCND3—Neuronal System—MDM2—sarcoma	0.000511	0.00288	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—PLCG1—sarcoma	0.000504	0.00284	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—PLCG1—sarcoma	0.000504	0.00284	CbGpPWpGaD
Dalfampridine—Hypersensitivity—Doxorubicin—sarcoma	0.000501	0.00232	CcSEcCtD
Dalfampridine—KCNB1—Neuronal System—MDM2—sarcoma	0.000498	0.00281	CbGpPWpGaD
Dalfampridine—KCNA1—Neuronal System—CREB1—sarcoma	0.000488	0.00275	CbGpPWpGaD
Dalfampridine—Asthenia—Doxorubicin—sarcoma	0.000488	0.00226	CcSEcCtD
Dalfampridine—Dizziness—Epirubicin—sarcoma	0.000486	0.00225	CcSEcCtD
Dalfampridine—KCNH7—Neuronal System—CREB1—sarcoma	0.000481	0.00271	CbGpPWpGaD
Dalfampridine—Vomiting—Epirubicin—sarcoma	0.000467	0.00216	CcSEcCtD
Dalfampridine—Rash—Epirubicin—sarcoma	0.000463	0.00215	CcSEcCtD
Dalfampridine—Dermatitis—Epirubicin—sarcoma	0.000463	0.00214	CcSEcCtD
Dalfampridine—Headache—Epirubicin—sarcoma	0.00046	0.00213	CcSEcCtD
Dalfampridine—KCND2—Neuronal System—MDM2—sarcoma	0.000456	0.00257	CbGpPWpGaD
Dalfampridine—KCNQ1—Neuronal System—MDM2—sarcoma	0.000456	0.00257	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—JUN—sarcoma	0.00045	0.00254	CbGpPWpGaD
Dalfampridine—Dizziness—Doxorubicin—sarcoma	0.00045	0.00208	CcSEcCtD
Dalfampridine—KCNH6—Neuronal System—MDM2—sarcoma	0.000447	0.00252	CbGpPWpGaD
Dalfampridine—Nausea—Epirubicin—sarcoma	0.000437	0.00202	CcSEcCtD
Dalfampridine—Vomiting—Doxorubicin—sarcoma	0.000432	0.002	CcSEcCtD
Dalfampridine—Rash—Doxorubicin—sarcoma	0.000429	0.00199	CcSEcCtD
Dalfampridine—Dermatitis—Doxorubicin—sarcoma	0.000428	0.00198	CcSEcCtD
Dalfampridine—Headache—Doxorubicin—sarcoma	0.000426	0.00197	CcSEcCtD
Dalfampridine—KCNQ2—Axon guidance—KDR—sarcoma	0.000414	0.00234	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—KDR—sarcoma	0.000414	0.00234	CbGpPWpGaD
Dalfampridine—KCNQ2—Neuronal System—CREB1—sarcoma	0.000409	0.00231	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—CREB1—sarcoma	0.000409	0.00231	CbGpPWpGaD
Dalfampridine—KCNH4—Neuronal System—HRAS—sarcoma	0.000405	0.00228	CbGpPWpGaD
Dalfampridine—KCNG4—Neuronal System—HRAS—sarcoma	0.000405	0.00228	CbGpPWpGaD
Dalfampridine—KCNC3—Neuronal System—HRAS—sarcoma	0.000405	0.00228	CbGpPWpGaD
Dalfampridine—KCNF1—Neuronal System—HRAS—sarcoma	0.000405	0.00228	CbGpPWpGaD
Dalfampridine—KCNH5—Neuronal System—HRAS—sarcoma	0.000405	0.00228	CbGpPWpGaD
Dalfampridine—KCNC4—Neuronal System—HRAS—sarcoma	0.000405	0.00228	CbGpPWpGaD
Dalfampridine—KCNA2—Neuronal System—HRAS—sarcoma	0.000405	0.00228	CbGpPWpGaD
Dalfampridine—KCNV1—Neuronal System—HRAS—sarcoma	0.000405	0.00228	CbGpPWpGaD
Dalfampridine—KCNH8—Neuronal System—HRAS—sarcoma	0.000405	0.00228	CbGpPWpGaD
Dalfampridine—KCNG1—Neuronal System—HRAS—sarcoma	0.000405	0.00228	CbGpPWpGaD
Dalfampridine—KCNH3—Neuronal System—HRAS—sarcoma	0.000405	0.00228	CbGpPWpGaD
Dalfampridine—KCNB2—Neuronal System—HRAS—sarcoma	0.000405	0.00228	CbGpPWpGaD
Dalfampridine—KCND1—Neuronal System—HRAS—sarcoma	0.000405	0.00228	CbGpPWpGaD
Dalfampridine—KCNV2—Neuronal System—HRAS—sarcoma	0.000405	0.00228	CbGpPWpGaD
Dalfampridine—KCNA10—Neuronal System—HRAS—sarcoma	0.000405	0.00228	CbGpPWpGaD
Dalfampridine—KCNA5—Neuronal System—HRAS—sarcoma	0.000405	0.00228	CbGpPWpGaD
Dalfampridine—KCNG3—Neuronal System—HRAS—sarcoma	0.000405	0.00228	CbGpPWpGaD
Dalfampridine—KCNS1—Neuronal System—HRAS—sarcoma	0.000405	0.00228	CbGpPWpGaD
Dalfampridine—KCNA4—Neuronal System—HRAS—sarcoma	0.000405	0.00228	CbGpPWpGaD
Dalfampridine—KCNA7—Neuronal System—HRAS—sarcoma	0.000405	0.00228	CbGpPWpGaD
Dalfampridine—KCNA6—Neuronal System—HRAS—sarcoma	0.000405	0.00228	CbGpPWpGaD
Dalfampridine—KCNC1—Neuronal System—HRAS—sarcoma	0.000405	0.00228	CbGpPWpGaD
Dalfampridine—KCNS2—Neuronal System—HRAS—sarcoma	0.000405	0.00228	CbGpPWpGaD
Dalfampridine—KCNH1—Neuronal System—HRAS—sarcoma	0.000405	0.00228	CbGpPWpGaD
Dalfampridine—KCNA1—Neuronal System—MDM2—sarcoma	0.000404	0.00228	CbGpPWpGaD
Dalfampridine—Nausea—Doxorubicin—sarcoma	0.000404	0.00187	CcSEcCtD
Dalfampridine—KCNH7—Neuronal System—MDM2—sarcoma	0.000398	0.00225	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—ENO2—sarcoma	0.000366	0.00207	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—ENO2—sarcoma	0.000366	0.00207	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—ENO2—sarcoma	0.000366	0.00207	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—HBA1—sarcoma	0.000364	0.00205	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—HBA1—sarcoma	0.000364	0.00205	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—HBA1—sarcoma	0.000364	0.00205	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—CREB1—sarcoma	0.000363	0.00205	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—CREB1—sarcoma	0.000363	0.00205	CbGpPWpGaD
Dalfampridine—KCNA3—Neuronal System—HRAS—sarcoma	0.000361	0.00203	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—FOXO1—sarcoma	0.000357	0.00202	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—FOXO1—sarcoma	0.000357	0.00202	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ENO2—sarcoma	0.000347	0.00196	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—HBA1—sarcoma	0.000345	0.00195	CbGpPWpGaD
Dalfampridine—KCNQ4—Neuronal System—HRAS—sarcoma	0.000344	0.00194	CbGpPWpGaD
Dalfampridine—KCNQ5—Neuronal System—HRAS—sarcoma	0.000344	0.00194	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—TP53—sarcoma	0.00034	0.00192	CbGpPWpGaD
Dalfampridine—KCNQ2—Neuronal System—MDM2—sarcoma	0.000339	0.00191	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—MDM2—sarcoma	0.000339	0.00191	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—MMP2—sarcoma	0.000338	0.00191	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—MMP2—sarcoma	0.000338	0.00191	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—CREB1—sarcoma	0.000325	0.00183	CbGpPWpGaD
Dalfampridine—CYP2E1—Tryptophan metabolism—MDM2—sarcoma	0.000323	0.00182	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PLCG1—sarcoma	0.000311	0.00175	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PLCG1—sarcoma	0.000311	0.00175	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PLCG1—sarcoma	0.000311	0.00175	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—TP53—sarcoma	0.000297	0.00168	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—KDR—sarcoma	0.000296	0.00167	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—KDR—sarcoma	0.000296	0.00167	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PLCG1—sarcoma	0.000295	0.00166	CbGpPWpGaD
Dalfampridine—KCNG2—Neuronal System—HRAS—sarcoma	0.000288	0.00163	CbGpPWpGaD
Dalfampridine—KCNC2—Neuronal System—HRAS—sarcoma	0.000288	0.00163	CbGpPWpGaD
Dalfampridine—KCNS3—Neuronal System—HRAS—sarcoma	0.000288	0.00163	CbGpPWpGaD
Dalfampridine—KCND3—Neuronal System—HRAS—sarcoma	0.000281	0.00158	CbGpPWpGaD
Dalfampridine—KCNB1—Neuronal System—HRAS—sarcoma	0.000273	0.00154	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—CREB1—sarcoma	0.000259	0.00146	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—CREB1—sarcoma	0.000259	0.00146	CbGpPWpGaD
Dalfampridine—KCNQ1—Neuronal System—HRAS—sarcoma	0.00025	0.00141	CbGpPWpGaD
Dalfampridine—KCND2—Neuronal System—HRAS—sarcoma	0.00025	0.00141	CbGpPWpGaD
Dalfampridine—KCNH6—Neuronal System—HRAS—sarcoma	0.000245	0.00138	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MMP2—sarcoma	0.000241	0.00136	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MMP2—sarcoma	0.000241	0.00136	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—SRC—sarcoma	0.000234	0.00132	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—SRC—sarcoma	0.000234	0.00132	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—JUN—sarcoma	0.000233	0.00132	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—CTNNB1—sarcoma	0.000232	0.00131	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—VEGFA—sarcoma	0.000228	0.00129	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—VEGFA—sarcoma	0.000228	0.00129	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—NRAS—sarcoma	0.000225	0.00127	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—NRAS—sarcoma	0.000225	0.00127	CbGpPWpGaD
Dalfampridine—KCNA1—Neuronal System—HRAS—sarcoma	0.000222	0.00125	CbGpPWpGaD
Dalfampridine—KCNH7—Neuronal System—HRAS—sarcoma	0.000219	0.00123	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—EGFR—sarcoma	0.000205	0.00116	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—EGFR—sarcoma	0.000205	0.00116	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—VEGFA—sarcoma	0.000204	0.00115	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—CREB1—sarcoma	0.000204	0.00115	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—KRAS—sarcoma	0.000194	0.00109	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—KRAS—sarcoma	0.000194	0.00109	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—HRAS—sarcoma	0.000186	0.00105	CbGpPWpGaD
Dalfampridine—KCNQ2—Neuronal System—HRAS—sarcoma	0.000186	0.00105	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—CTNNB1—sarcoma	0.000185	0.00104	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—CTNNB1—sarcoma	0.000185	0.00104	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—MDM2—sarcoma	0.000169	0.000951	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—SRC—sarcoma	0.000167	0.000943	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—SRC—sarcoma	0.000167	0.000943	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—HRAS—sarcoma	0.000165	0.00093	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—HRAS—sarcoma	0.000165	0.00093	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—VEGFA—sarcoma	0.000163	0.000918	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—VEGFA—sarcoma	0.000163	0.000918	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—NRAS—sarcoma	0.000161	0.000907	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—NRAS—sarcoma	0.000161	0.000907	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—EGFR—sarcoma	0.000147	0.000826	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—EGFR—sarcoma	0.000147	0.000826	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—KRAS—sarcoma	0.000138	0.000781	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—KRAS—sarcoma	0.000138	0.000781	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—HRAS—sarcoma	0.000118	0.000664	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—HRAS—sarcoma	0.000118	0.000664	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—HRAS—sarcoma	9.25e-05	0.000522	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ENO2—sarcoma	5.32e-05	0.0003	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—HBA1—sarcoma	5.29e-05	0.000298	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PLCG1—sarcoma	4.52e-05	0.000255	CbGpPWpGaD
